SOPHiA GENETICS (SOPH) Receivables (2020 - 2025)

SOPHiA GENETICS has disclosed Receivables across 6 years of filings, most recently posting $15.0 million for Q4 2025.

• Receivables for Q4 2025 came in at $15.0 million, up 101.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $15.0 million (up 101.73% YoY), and the FY2025 annual result was $15.0 million, up 101.73% from the prior year.
• Receivables came in at $15.0 million for Q4 2025 at SOPHiA GENETICS, up from $8.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $15.0 million in Q4 2025 to a low of $6.1 million in Q4 2022.
• The 5-year median for Receivables is $9.5 million (2025), against an average of $9.1 million.
• Across the five-year window, Receivables surged 123.71% in 2023 and slumped 45.15% in 2024, its largest moves.
• SOPHiA GENETICS's Receivables stood at $6.3 million in 2021, then retreated by 3.47% to $6.1 million in 2022, then soared by 123.71% to $13.6 million in 2023, then plunged by 45.15% to $7.4 million in 2024, then soared by 101.73% to $15.0 million in 2025.
• The last three Receivables figures came in at $15.0 million (Q4 2025), $8.5 million (Q3 2025), and $9.5 million (Q2 2025), per Business Quant data.